Vascular smooth muscle cell signaling in cirrhosis and portal hypertension

Pharmacology and Therapeutics

Volumn 89, Issue 3, 2001, Pages 255-272

  Bomzon, Arieh ^a   Huang, Yi Tsau ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Calcium; Cirrhosis; Portal hypertension; Signal transduction; Vascular hyporesponsiveness; Vascular smooth muscle cells

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; DIACYLGLYCEROL; G PROTEIN COUPLED RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE; LIGAND; PROTEIN KINASE C; PROTEIN TYROSINE KINASE;

ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM SIGNALING; CELL DAMAGE; CYCLIC AMP BLOOD LEVEL; HUMAN; LIVER CIRRHOSIS; MUSCLE FIBER CONTRACTION; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE RELAXATION; SPLANCHNIC BLOOD FLOW; VASCULAR SMOOTH MUSCLE;

EID: 0034976228     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(01)00127-9     Document Type: Review

References (103)

1. Signal transduction in vascular smooth muscle
2. Prolonged infusion of angiotensin II and norepinephrine on blood pressure, electrolyte balance and aldosterone and cortisol secretion in normal man and cirrhosis with ascites
3. Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion
4. Circulating levels of endothelin in cirrhosis
5. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
6. Angiotensin II signal transduction in vascular smooth muscle: Pathways activated by specific tyrosine kinases
7. Angiotensin II signal transduction in vascular smooth muscle - Role of tyrosine kinases
8. The renin-angiotensin-aldosterone system in liver disease
9. Inositol triphosphate and calcium signalling
10. Sodium/calcium exchange: Its physiological implications
11. What regulates activator calcium
12. Vascular reactivity in experimental portal hypertension
13. Animal models of liver disease
14. In vitro vascular responsiveness to norepinephrine in experimental portal hypertension
15. Pressor response to a postural change in cirrhosis: An experimental study in the CCl4-treated rat
16. Hypotension in experimental cirrhosis. Is loss of vascular responsiveness to norepinephrine the cause of hypotension in chronic bile-duct-ligated dogs
17. Impaired skeletal muscle vasomotor response to infused noradrenaline in baboons with obstructive jaundice
18. + from SR in vascular smooth muscle cells
19. Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle
20. Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits
21. Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: Role in splanchnic hemodynamics
22. Endothelial dysfunction in cirrhosis and portal hypertension
23. Impaired responsiveness to angiotensin II in experimental cirrhosis: Role of nitric oxide
24. Intracellular calcium concentration in vascular smooth muscle cells of rats with cirrhosis
25. Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats
26. Regulation of vascular tone: Cross-talk between sarcoplasmic reticulum and plasmalemma
27. Enhanced urinary excretion of cGMP in liver cirrhosis - Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion
28. Portal hypertension induces sodium channels in luminal colonocytes from the distal colon of the portal stenotic rat
29. Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats
30. Na restriction blunts expansion of plasma volume and ameliorates hyperdynamic circulation in portal hypertension
31. Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: Role of splanchnic and renal passage and liver function
32. Protein kinase C isoforms in human aortic smooth muscle cells
33. Endothelial control of the cardiovascular system
34. Angiotensin II signaling in vascular smooth muscle
35. Cirrhosis of the liver and receptor-mediated function in vascular smooth muscle
36. Portal vein prostacyclin activity in experimental portal hypertension in rats
37. The relationship between prostacyclin activity and pressure in the portal vein
38. Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis
39. The role of prostacyclin in patients with portal hypertension
40. Hepatorenal disorders: Role of the sympathetic nervous system
41. The acute actions of growth factors in smooth muscle systems
42. Tyrosine kinase pathways and the regulation of smooth muscle contractility
43. Change in vascular cAMP and cGMP contents in portal hypertensive rats
44. Decreased vascular contractile and inositol phosphate responses in portal hypertensive rats
45. Decreased vascular reactivity of portal vein in rats with portal hypertension
46. Vascular hyporesponsiveness in aorta from portal hypertensive rats: Possible sites of involvement
47. Inositol phosphate responses in portal veins from portal hypertensive rats: Receptor- and nonreceptor mediated responses
48. The adenylyl cyclases as integrators of transmembrane signal transduction
49. Cardiovascular responses to serotonin in experimental liver disease
50. Mechanical, morphological and pharmacological properties of oesophageal varices and small mesenteric veins in portal hypertensive rabbits
51. Altered prostacyclin synthesis by aortae from hepatic portal vein-constricted rats: Evidence for effects on protein kinase C and calcium
52. Activation of membrane receptors
53. Intestinal microvascular responsiveness to norepinephrine in chronic portal hypertension
54. Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle
55. Time course of development of changes in the structure and reactivity of small veins from portal hypertensive rabbits
56. Signaling through receptor tyrosine kinases
57. Hormones and the pathogenesis of congestive heart failure: Vasopressin, aldosterone and angiotensin II. Further evidence for renal-adrenal interaction from studies in hypertension and in cirrhosis
58. Angiotensin II, norepinephrine and renal transport of electrolytes and water in normal man and cirrhosis with ascites
59. Signal transduction in vascular smooth muscle: Diacylglycerol second messengers and PKC action
60. Vasodilatory responses of isolated arteries of cirrhotic rats
61. Signal transduction of mechanical stresses in the vascular wall
62. Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation
63. Cyclic nucleotides regulate the activity of L-type calcium channels in smooth muscle cells from rat portal vein
64. Regulation of sodium-hydrogen exchange in vascular smooth muscle
65. Skeletal muscle blood flow and neurovascular reactivity in liver disease
66. Impaired cardiovascular responsiveness in liver disease
67. Cell signalling pathways involved in the regulation of vascular smooth muscle contraction and relaxation
68. Elevated plasma glucagon levels in cirrhosis of the liver
69. 2+-pump activity in hearts perfused with oxygen free radicals
70. Endothelium, coronary vasodilation, and organic nitrates
71. Elevated circulating plasma endothelin-1 concentrations in cirrhosis
72. Contributo allo studio della reattivitå vascolare periferica all'angiotensina ed alla noradrenalina in corso di affezioni epatiche
73. La risposta pressoria all'angiotensina e alla noradrenalina in soggetti con affezioni epatiche
74. Signal transduction using nitric oxide and cyclic guanosine monophosphate
75. Decreased pressor reactivity to angiotensin II in cirrhotic rats. Evidence for a post-receptor defect in angiotensin action
76. Identification of protein kinase C isoforms in rat mesenteric small arteries and their possible role in agonist-induced contraction
77. Hyperglucagonemia and hyperdynamic circulation in rats with biliary cirrhosis
78. Mechanotransduction by vascular smooth muscle
79. Glucagon in portal hypertension
80. A functional PtdIns(3)P-binding motif
81. In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure
82. Initiation of smooth muscle response
83. Endothelin and vascular reactivity in cirrhosis
84. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model
85. Evidence for role of prostacyclin as a systemic hormone in portal hypertension
86. Evidence for normal nitric oxide-mediated vasodilator tone in conscious rats with cirrhosis
87. MAP kinases and vascular smooth muscle function
88. 2+, protein kinase C and myosin light chain phosphatase
89. Altered growth and lack of responsiveness to angiotensin II in aortic vascular smooth muscle cells from cirrhotic rats
90. Responsiveness to growth factors in aortic vascular smooth muscle cells from rats with cirrhosis
91. Changes in protein kinase C isoforms in association with vascular hyporeactivity in cirrhotic rat aortas
92. Angiotensin II modulates atrial natriuretic factor-induced natriuresis in cirrhosis with ascites
93. Protein kinase C alterations in aortic vascular smooth muscle cells from rats with cirrhosis
94. Regulation of vascular smooth muscle tone
95. Intracellular mechanisms involved in the regulation of vascular smooth muscle tone
96. Atrial natriuretic factor and liver disease
97. Regulation of smooth muscle actin-myosin interaction and force by calponin
98. Pathophysiology of sodium retention and ascites formation in cirrhosis: Role of atrial natriuretic factor
99. Effects of sodium status on the venous response to noradrenaline infusion in pre-ascitic cirrhosis
100. Nonreceptor-mediated intestinal vasoconstriction in portal hypertensive rats
101. Altered vascular norepinephrine responses in portal hypertensive intestine: Role of PKA and guanylate cyclase
102. Regulation of L-type calcium channels of vascular smooth muscle cells
103. Distinct signal transduction pathways for angiotensin-II in guinea pig gastric smooth muscle: Differential blockade by indomethacon and tyrosine kinase inhibitors